Eutropoflavin

All information provided here is for informational purposes only and may contain inaccuracies. These products are intended for collectors, hobbyists, and for educational and research purposes only. Not for use by humans or animals.

Eutropoflavin, or 4′-Dimethylamino-7,8-dihydroxyflavone in chemical nomenclature, has been derived from structural modification of a naturally occurring flavonoid, tropoflavin (7,8-dihydroxyflavone). The addition of a dimethylamino group at the 4′ position increases the molecule’s lipophilcity (affinity for lipids), which potentiates its ability to cross the blood-brain barrier. Just like its parent compound, it is a selective small-molecule agonist of the tropomyosin receptor kinase B (TrkB), the main signaling receptor of BDNF (brain-derived neurotrophic factor). However, in comparison with tropoflavin, it possesses much higher  TrkB affinity and shows significant superiority in duration.

Thus far, eutropoflavin has attracted scientific interest due to its supposed cognitive-enhancing properties and unparalleled mechanism of action. Existing studies, primarily in animal models, have investigated its effects on neuroplasticity and brain activity. The compound’s ability to mimic BDNF and acivate TrkB receptor has sparked scientific interest with regard to its potential appications in neurodegenerative and neurodevelopmental disorders.

It is important to note that eutropoflavin is still a relatively unknown compound, and while it shows promise when compared to various well-studied nootropics, futher studies are required in order to fully understand its potential and assess its long-lasting benefits. While there have been numerous anecdotal reports that highlight a vide range of experienced benefits, including its effects on memory and learning and mood enhancement, more rigorous and comprehensive research is necessary in order to generize and systematize those findings, the safety profile of eutropoflavin and as well as establish the optimum dosage scheme.